# MoonLake Immunotherapeutics: Form SC 13D, filed Apr 18, 2022

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: SC 13D
- Filed: 2022-04-18
- Accepted by EDGAR: Apr 18, 2022, 16:49 ET
- Period: not reported
- Accession: 0000921895-22-001288
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000092189522001288/sc13d07422010_04182022.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000092189522001288/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000092189522001288/sc13d07422010_04182022.htm

Filed Apr 18, 2022.
Source: SEC EDGAR, the filing index for accession 0000921895-22-001288. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.
